The report provides a detailed analysis essential for establishing a Valsartan production plant. It encompasses all critical aspects necessary for Valsartan production, including the cost of Valsartan production, Valsartan plant cost, Valsartan production costs, and the overall Valsartan production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Valsartan production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Valsartan is a member of the angiotensin II receptor blocker class of drugs. It is an antihypertensive drug used to treat hypertension and heart failure. It is prescribed to treat hypertension to lower the risk of both fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarctions. It can also be used to treat heart failure and left ventricular dysfunction or failure following a myocardial infarction. Valsartan also has an impact on the renin-angiotensin-aldosterone system (RAAS). Thus, it finds its application in the pharmaceutical and medical industries.
The procurement of Valsartan is influenced by its application in the pharmaceutical and medical industries as an antihypertensive drug used to treat hypertension, and related cardiac abnormalities. The need for Valsartan is increasing as cases of hypertension and cardiac disorders are on the rise. It witnesses a significant demand from the aging population as they are more likely to be affected by hypertension and other cardiac disorders. The ability to block all angiotensin II activity, independent of the source or method of synthesis, is what distinguishes Valsartan from other drugs. In individuals who cannot tolerate ACE inhibitors, Valsartan is frequently used to treat hypertension, heart failure, and Type 2 Diabetes-related nephropathy.
Numerous large-scale clinical outcome trials have demonstrated that ARBs, including Valsartan, enhance cardiovascular outcomes, including lowering the risk of myocardial infarction, stroke, the advancement of heart failure, and hospitalization, thus increasing its demand. Overall, the industrial Valsartan procurement is influenced by its application in the pharmaceutical and medical industries as an antihypertensive medication, the rising cases of hypertension and cardiovascular disorders, the aging population, its wide range of applications, research and development, better tolerability, fewer side effects, cost-effectiveness, increasing healthcare awareness, and regulatory approvals.
Raw Material for Valsartan Production
According to the Valsartan production plant project report, the key raw material used in the production of Valsartan include 4-methyl-2-cyano-biphenyl.
Production Process of Valsartan
The extensive Valsartan production cost report consists of the following major industrial production process:
- Production from 4’-methyl-2-cyano-biphenyl: The production process of Valsartan has several key steps. In the first step, 4'-methyl-2-cyano-biphenyl is converted to a tetrazole ring using sodium azide and Et3N*HCl as a catalyst, forming pure biphenyltetrazole after neutralization, extraction, and reacidification. The tetrazole ring is then protected with trityl chloride in dichloromethane and triethylamine. The protected compound is then selectively brominated using N-bromosuccinimide in tetrachloromethane with 2,2’-azobisisobutyronitrile (AIBN) to form 4’-bromo-methyl-2-(N-trityl-1H-tetrazol-5-yl)-biphenyl. The desired product is then produced by benzolation with L-valine methyl ester hydrochloride in ACN and K2CO3; this is followed by acylation with valeroyl chloride and removal of the trityl group with HCl in methanol, producing the free tetrazole compound. In the final step, Valsartan is obtained by hydrolysis with NaOH.
Valsartan, commercially known as Diovan, is a white powder having the molecular formula C24H29N5O3 and a molecular weight of 435.5 g/mol. It melts at 116-117 °C. Its boiling point is 83-88 °C. It dissolves in ethanol, DMSO, and dimethylformamide at 30 mg/mL. Its water solubility is 0.0234 mg/mL. Its log P value is 1.499. Its pKa value is 4.73. It is an antihypertensive medication used to treat high blood pressure and related cardiovascular abnormalities.
